Print this page    •   Back to Web version of article

Trying to Produce Drugs Appropriate for Children With HIV

June 20, 2014

This article was reported by the The Washington Post.

The Washington Post reported that on June 17, the Geneva-based Medicines Patent Pool kicked off an initiative in conjunction with other agencies to encourage major drug companies to manufacture and distribute HIV drugs in the correct formulation for children. While the United States has nearly eliminated pediatric HIV through the use of drugs for pregnant women, Medicines Patent Pool Executive Director Greg Perry notes that fewer than 25 percent of the 3.4 million children with HIV/AIDS globally -- most living in sub-Saharan Africa -- are receiving the antiretroviral therapy they need. The pills often are too big for small children, have an unpleasant taste, and contain alcohol. Joining in the initiative are UNITAID and the Drugs for Neglected Diseases Initiative. Drug manufacturers Gilead and Bristol-Myers Squibb have agreed to share knowledge, and the initiative is in talks with Merck and AbbVie.

Back to other news for June 2014

This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update. You can find this article online by typing this address into your Web browser:

General Disclaimer: is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.